We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSKN
4726
DELISTED
Strata Skin Sciences
SSKN
$74K ﹤0.01%
4,060
BRQS
4727
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$74K ﹤0.01%
655
+388
+145% +$58.5K
UNCY icon
4728
Unicycive Therapeutics
UNCY
$137M
$73K ﹤0.01%
+2,611
New +$74.9K
MAAS
4729
Maase Inc
MAAS
$9.24B
$73K ﹤0.01%
205
CYAN
4730
DELISTED
Cyanotech Corp
CYAN
$73K ﹤0.01%
25,490
IMMP
4731
Immutep
IMMP
$58M
$72K ﹤0.01%
18,722
+6,591
+54% +$24.6K
ITRM
4732
DELISTED
Iterum Therapeutics
ITRM
$72K ﹤0.01%
8,618
+1,878
+28% +$23.1K
JFU
4733
9F Inc
JFU
$24.1M
$72K ﹤0.01%
2,127
ONCY
4734
Oncolytics Biotech
ONCY
$97.9M
$72K ﹤0.01%
34,659
+10,114
+41% +$22.9K
DRMA icon
4735
Dermata Therapeutics
DRMA
$4.34M
$71K ﹤0.01%
+7
New +$82.8K
IPDN icon
4736
Professional Diversity Network
IPDN
$5.13M
$71K ﹤0.01%
2,852
+1,101
+63% +$31.2K
XMAX
4737
XMAX Inc
XMAX
$594M
$71K ﹤0.01%
6,283
+1,050
+20% +$13.8K
VIRC icon
4738
Virco
VIRC
$92.2M
$71K ﹤0.01%
20,825
MIRO
4739
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$71K ﹤0.01%
+10,203
New +$96.2K
APTO
4740
DELISTED
Aptose Biosciences, Inc.
APTO
$70K ﹤0.01%
72
-59
-45% -$73.8K
KAVL
4741
DELISTED
Kaival Brands Innovations Group
KAVL
$69K ﹤0.01%
+2,406
New +$259K
MTCR
4742
DELISTED
Metacrine, Inc. Common Stock
MTCR
$69K ﹤0.01%
20,312
-7,942
-28% -$24.8K
HCWB icon
4743
HCW Biologics
HCWB
$5.06M
$68K ﹤0.01%
+89
New +$93.6K
JWEL icon
4744
Jowell Global
JWEL
$9.29M
$68K ﹤0.01%
734
MOVE icon
4745
Corvex Inc
MOVE
$304M
$68K ﹤0.01%
173
+23
+15% +$10.8K
TOMZ icon
4746
TOMI Environmental Solutions
TOMZ
$13.3M
$68K ﹤0.01%
16,683
CSCI
4747
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$68K ﹤0.01%
915
+384
+72% +$27.3K
FWDI
4748
Forward Industries Inc
FWDI
$316M
$67K ﹤0.01%
2,814
+381
+16% +$9.74K
TRVI icon
4749
Trevi Therapeutics
TRVI
$2.54B
$67K ﹤0.01%
49,077
STAF
4750
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$67K ﹤0.01%
344
+287
+504% +$73.9K

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.